XML 33 R29.htm IDEA: XBRL DOCUMENT v2.4.0.6
FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS: (Tables)
3 Months Ended
Mar. 31, 2013
FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS:  
Schedule of fair value and balance sheet location of the Company's derivative instruments

 

 

 

 

 

March 31, 2013

 

December 31, 2012

 

($ in millions)

 

Balance Sheet Location

 

Notional

 

Fair Value

 

Notional

 

Fair Value

 

Derivatives Designated as Hedging Instruments:

 

 

 

 

 

 

 

 

 

 

 

Foreign exchange contracts

 

Accrued expenses and other current liabilities

 

$

12.6

 

$

0.1

 

$

—

 

$

—

 

Total derivatives designated as hedging instruments

 

 

 

 

 

$

0.1

 

 

 

$

—

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivatives Not Designated as Hedging Instruments:

 

 

 

 

 

 

 

 

 

 

 

Interest rate swaps

 

Accrued expenses and other current liabilities

 

$

—

 

$

—

 

$

662.9

 

$

3.0

 

 

 

Other liabilities

 

 

 

—

 

 

 

1.8

 

Total derivatives not designated as hedging instruments

 

 

 

 

 

$

—

 

 

 

$

4.8

 

Total derivatives

 

 

 

 

 

$

0.1

 

 

 

$

4.8

 

Schedule of gains and losses reported in "Other Comprehensive Income" ("OCI") within Equity

 

 

 

Amount of Gain or (Loss) Recognized in

 

 

 

OCI on Derivatives and Other Financial

 

 

 

Instruments (Effective Portion)

 

 

 

Three months ended March 31,

 

($ in millions)

 

2013

 

2012

 

Derivatives Designated as Cash Flow Hedges:

 

 

 

 

 

Foreign exchange contracts

 

$

(0.1

)

$

0.1

 

 

 

 

 

 

 

Non-Derivative Debt Designated as Net Investment Hedge:

 

 

 

 

 

Euro-denominated debt

 

$

—

 

$

(0.3

)

Schedule of gains and losses reported in the condensed consolidated statements of operations

 

 

 

Amount of Gain or (Loss)

 

 

 

 

 

Recognized in Income on Derivatives

 

Location of Gain or (Loss)

 

 

 

Three months ended March 31,

 

Recognized in Income on

 

($ in millions)

 

2013

 

2012

 

Derivatives

 

Derivatives Not Designated as Hedging Instruments:

 

 

 

 

 

 

 

Interest rate swaps

 

$

0.9

 

$

(0.4

)

Interest expense, net

 

Total derivatives

 

$

0.9

 

$

(0.4

)

 

 

Schedule of fair value of the Company's recurring financial assets and liabilities that are required to be measured at fair value in the condensed consolidated balance sheets

 

 

 

As of March 31, 2013

 

As of December 31, 2012

 

($ in millions)

 

Total

 

Level 1

 

Level 2

 

Total

 

Level 1

 

Level 2

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents

 

$

325.2

 

$

325.2

 

$

—

 

$

1,110.1

 

$

1,110.1

 

$

—

 

Government securities

 

0.3

 

0.3

 

—

 

0.3

 

0.3

 

—

 

Marketable equity securities

 

—

 

—

 

—

 

2.2

 

2.2

 

—

 

Total assets at fair value

 

$

325.5

 

$

325.5

 

$

—

 

$

1,112.6

 

$

1,112.6

 

$

—

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign exchange contracts

 

$

0.1

 

$

—

 

$

0.1

 

$

—

 

$

—

 

$

—

 

Interest rate swaps

 

—

 

—

 

—

 

4.8

 

—

 

4.8

 

Total liabilities at fair value

 

$

0.1

 

$

—

 

$

0.1

 

$

4.8

 

$

—

 

$

4.8